NCT01634087View on ClinicalTrials.gov

A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

February 28, 2013

Conditions

Plaque Psoriasis

Interventions

DRUG

Itacitinib

Itacitinib administered orally

DRUG

Placebo

Placebo administered orally

Trial Locations (9)

Unknown

Hot Springs

Los Angeles

Clinton

Fridley

Rochester

Moncton

Windsor

Montreal

Québec

Sponsors

Lead Sponsor

Incyte Corporation

All Listed Sponsors

lead

Incyte Corporation

INDUSTRY